Blog

Sirion Biotech GmbH: Next-generation AAV gene therapy from joined German forces – Markets Insider

Sirion Biotech GmbH: Next-generation AAV gene therapy from joined German forces
Markets Insider
The tremendous potential of this versatile vector class is undisputed and illustrated by its growing presence in clinical gene therapy trials. While individual applications have already yielded promising results, culminating in the commercialization of

2018-05-30 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.